Carolinas Wealth Consulting’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10
Closed -$568 141
2025
Q1
$568 Sell
10
-5
-33% -$312 ﹤0.01% 958
2024
Q4
$1.04K Sell
15
-51
-77% -$4.9K ﹤0.01% 941
2024
Q3
$8.97K Hold
66
﹤0.01% 577
2024
Q2
$8.9K Sell
66
-2
-3% -$306 ﹤0.01% 575
2024
Q1
$11.7K Buy
68
+2
+3% +$305 ﹤0.01% 544
2023
Q4
$10.3K Buy
+66
New +$8.61K ﹤0.01% 538
2022
Q4
Sell
-6
Closed -$1K 1074
2022
Q3
$1K Sell
6
-240
-98% -$26.4K ﹤0.01% 800
2022
Q2
$29K Hold
246
0.01% 401
2022
Q1
$35K Hold
246
0.01% 402
2021
Q4
$41K Sell
246
-1
-0.4% -$163 0.01% 389
2021
Q3
$37K Hold
247
0.01% 384
2021
Q2
$37K Buy
247
+130
+111% +$20.6K 0.01% 399
2021
Q1
$18K Buy
117
+105
+875% +$14.4K ﹤0.01% 525
2020
Q4
$2K Hold
12
﹤0.01% 734
2020
Q3
$1K Buy
+12
New +$1.2K ﹤0.01% 801

Other funds holding CE

Carolinas Wealth Consulting's CE Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Celanese (CE) in Q2 2025, closing a stake of 10 shares — an estimated $568 sold.

Carolinas Wealth Consulting first reported a position in CE in Q3 2020 and held it in 15 quarters. The position peaked at $41K in Q4 2021. 449 funds tracked by Wall St. Rank hold CE as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Celanese position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 10 Celanese shares in Q2 2025, an estimated $568.
  • Carolinas Wealth Consulting first reported a position in Celanese in Q3 2020 and held it in 15 quarters.
  • Carolinas Wealth Consulting's Celanese position peaked at $41K in Q4 2021.
  • 449 funds tracked by Wall St. Rank held Celanese as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.